• 제목/요약/키워드: IGFBP2

검색결과 100건 처리시간 0.03초

Insulin growth factor binding protein-3 enhances dental implant osseointegration against methylglyoxal-induced bone deterioration in a rat model

  • Takanche, Jyoti Shrestha;Kim, Ji-Eun;Jang, Sungil;Yi, Ho-Keun
    • Journal of Periodontal and Implant Science
    • /
    • 제52권2호
    • /
    • pp.155-169
    • /
    • 2022
  • Purpose: The aim of this study was to determine the effect of insulin growth factor binding protein-3 (IGFBP-3) on the inhibition of glucose oxidative stress and promotion of bone formation near the implant site in a rat model of methylglyoxal (MGO)-induced bone loss. Methods: An in vitro study was performed in MC3T3 E1 cells treated with chitosan gold nanoparticles (Ch-GNPs) conjugated with IGFBP-3 cDNA followed by MGO. An in vivo study was conducted in a rat model induced by MGO administration after the insertion of a dental implant coated with IGFBP-3. Results: MGO treatment downregulated molecules involved in osteogenic differentiation and bone formation in MC3T3 E1 cells and influenced the bone mineral density and bone volume of the femur and alveolar bone. In contrast, IGFBP-3 inhibited oxidative stress and inflammation and enhanced osteogenesis in MGO-treated MC3T3 E1 cells. In addition, IGFBP-3 promoted bone formation by reducing inflammatory proteins in MGO-administered rats. The application of Ch-GNPs conjugated with IGFBP-3 as a coating of titanium implants enhanced osteogenesis and the osseointegration of dental implants. Conclusions: This study demonstrated that IGFBP-3 could be applied as a therapeutic component in dental implants to promote the osseointegration of dental implants in patients with diabetes, which affects MGO levels.

Puberty Related Changes in Hormonal Levels, Productive Performance, Carcass Traits, and Their Interactions in Slovakian White Gilts

  • Kolesarova, A.;Sirotkin, A.V.;Roychoudhury, S.;Capcarova, M.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제23권2호
    • /
    • pp.182-187
    • /
    • 2010
  • The aim of this experiment was to evaluate the levels of hormones (progesterone, IGF-I and IGFBP-3) in blood plasma, growth, carcass traits and their interactions of sexually immature (n = 18) and sexually mature (n = 17) gilts. To calculate average daily weight gain (ADG), gilts were individually weighed at the beginning of the trial and at slaughter (110${\pm}$10 days old). Blood concentrations of progesterone, IGF-I and IGFBP-3 were determined by RIA. The right hot carcass sides were dissected and the individual basic parts from carcasses were weighed to record the carcass traits. IGFBP-3, ADG and carcass traits were not affected by pubertal maturation. Compared to sexually immature gilts, mature gilts had higher blood concentrations of progesterone and IGF-I. High correlations were noted between levels of some hormonal substances, productive performance and carcass traits of sexually immature and mature gilts.

Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs

  • Song, Doo-Won;Ro, Woong-Bin;Sur, Jung-Hyang;Seung, Byung-Joon;Kang, Hyun-Min;Kim, Jong-Won;Park, See-Hyoung;Park, Hee-Myung
    • Journal of Veterinary Science
    • /
    • 제22권6호
    • /
    • pp.77.1-77.10
    • /
    • 2021
  • Background: Serum-based parameters are considered non-invasive biomarkers for cancer detection. In human studies, insulin-like growth factor-I and II (IGF-I and IGF-II) and insulin-like growth factor binding protein-3 (IGFBP-3) are useful as diagnostic or prognostic markers and potential therapeutic targets. Objectives: This study examined the diagnostic utility of circulating IGF-I, IGF-II, and IGFBP-3 levels in healthy dogs and dogs with tumors. Methods: The serum concentrations of these biomarkers in 86 dogs with tumors were compared with those in 30 healthy dogs using an enzyme-linked immunosorbent assay (ELISA). Results: The ELISA results showed no difference between healthy dogs and dogs with tumors in the serum IGF-II concentrations. On the other hand, there was a significant difference in the circulating IGF-I and IGFBP-3 levels between healthy dogs and dogs with tumors. The concentrations of serum IGF-I (median [interquartile range], 103.4 [59.5-175] ng/mL) in dogs with epithelial tumors were higher than those (58.4 ng/mL [43.5-79.9]) in healthy dogs. Thus, the concentrations of serum IGFBP-3 (43.4 ng/mL [33.2-57.2]) in dogs with malignant mesenchymal tumors were lower than those (60.8 ng/mL [47.6-70.5]) in healthy dogs. Conclusions: The serum IGF-I and IGFBP-3 levels can be used as diagnostic biomarkers in dogs with tumors.

성장호르몬 결핍증 진단에 있어서 혈중 insulin-like growth factor-I 및 insulin-like growth factor binding protein-3 농도의 진단적 유용성에 대한 연구 (Study on the diagnostic utility of serum levels of insulin-like growth Factor-I and insulin-like growth factor binding protein-3 in growth hormone deficiency)

  • 지근하;이정녀;정우영
    • Clinical and Experimental Pediatrics
    • /
    • 제51권12호
    • /
    • pp.1329-1335
    • /
    • 2008
  • 목 적: 저자들은 한국 소아발육 표준치를 이용하여 25-50백분위수에 속하는 정상대조군 환자들의 혈중 I형 인슐린 양 성장인자(IGF-I)와 인슐린 양 성장인자 결합단백-3 (IGFBP-3) 농도의 SD치를 이용하여, 성장호르몬 결핍증을 진단하는데 있어서 검색검사로서의 진단적 유용성에 대한 분석을 시도하였다. 방 법: 성장호르몬 결핍증 환아 31명, 정상대조군 230명(남아 129명, 여아 101명)을 대상으로 하였다. 성장호르몬 결핍증 환자는 완전 결핍증 14명(남아 12명, 여아 2명), 부분 결핍증 17명(남아 9명, 여아 8명) 이었다. 연령분포는 7세에서 15세 사이였다. IGF-I은 RIA 방법으로, IGFBP-3는 IRMA 방법으로 측정하였다. 결 과: ROC 분석을 통해 얻어진 가장 가능성이 높은 절단치는 정상대조군에서 얻어진 혈중 농도의 -1 표준 편차에 해당하는 값과 유사하였다. 이를 토대로 하여 정상키를 가진 대조군의 혈중 IGF-I 농도의 -1 표준편차 값을 기준 절단치로 잡아 7-9세군, 10-12세군, 13-14세군 각각에서의 성장호르몬 결핍증의 민감도와 특이도를 계산하였을 때 민감도는 87.5-100%였고 특이도는 80-84.6%로 비슷하게 나타났다. 혈중 IGFBP-3는 민감도는 58.7-85.7%로 다소 차이가 많았고 특이도는 79.2-85.5%로 유사하였다. 전체 연령군을 대상으로 한 혈중 IGF-I의 진단적 정확도는 완전결핍 군에서 78.5%, 불완전결핍 군에서는 94.1%였다. 혈중 IGFBP-3의 진단적 정확도는 완전결핍 군에서 83.3%, 불완전결핍 군에서는 76.5%였다. 결 론: 성장호르몬 결핍증을 진단하기 위해서 외래에서 시행하는 일회성 검색검사로 혈중 IGF-I 및 IGFBP-3농도의 측정은 신체계측, 방사선학적 검사법등과 함께 유용하게 사용될 수 있을 것으로 판단되며, 본 연구에서는 절단치를 대조군으로부터 얻어진 혈중 평균농도치의 -1 표준 편차 값으로 잡았을 때 비교적 만족할 만한 결과를 얻었다고 생각한다.

Expression of Porcine Acid-labile Subunit (pALS) of the 150-kilodalton Ternary Insulin-like Growth Factor Complex and Initial Characterization of Recombinant pALS Protein

  • Lee, Dong-Hee;Chun, Choa;Kim, Sang-Hoon;Lee, C.-Young
    • BMB Reports
    • /
    • 제38권2호
    • /
    • pp.225-231
    • /
    • 2005
  • Acid-labile subunit (ALS) is a component of the 150-kDa insulin-like growth factor-binding protein-3 (IGFBP-3) complex, which, by sequestering the majority of IGFs-I and -II and thereby prolonging the half-life of them in plasma, serves as a circulating reservoir of IGFs in mammalian species. A pGEX-2T plasmid and a baculovirus expression constructs harboring a coding sequence for glutathione-S transferase (GST)-porcine ALS (pALS) fusion protein were expressed in BL21(DE3) E. coli and Sf9 insect cells, respectively. The expressed protein was purified by glutathione or Ni-NTN affinity chromatography, followed by cleavage of the fusion protein using Factor Xa. In addition, pALS and hIGFBP-3 were also produced in small amounts in the Xenopus oocyte expression system which does not require any purification procedure. A 65-kDa pALS polypeptide was obtained following the prokaryotic expression and the enzymatic digestion, but biochemical characterization of this polypeptide was precluded because of an extremely low expression efficiency. The baculovirus-as well as Xenopus-expressed pALS exhibited the expected molecular mass of 85 kDa which was reduced into 75 and 65 kDa following deglycosylation of Asn-linked carbohydrates by Endo-F glycosidase, indicating that the expressed pALS was properly glycosylated. Moreover, irrespective of the source of pALS, the recombinant pALS and hIGFBP-3 formed a 130-kDa binary complex which could be immunoprecipitated by anti-hIGFBP-3 antibodies. Collectively, results indicate that an authentic pALS protein can be produced by the current expression systems.

MCF-7 cell에서 all-trans retinoic acid에 의한 insulin-like growth factor-I와 insulin-like growth factor binding protein-3 분비조절에 있어서 PKC-δ의 역할 (The roles of PKC-δ on the regulation of insulin-like growth factor(IGF)-I and insulin-Like growth factor binding protein-3 secretion by all-trans retinoic acid in MCF-7 cell)

  • 이선미;김상훈;최광수;강창원
    • 대한수의학회지
    • /
    • 제46권2호
    • /
    • pp.97-105
    • /
    • 2006
  • All-trans retinoic acid (AtRA) induces growth inhibition and apoptosis in a variety of tumer cells, including MCF-7 cells. Insulin-like growth factors (IGFs) system has been reported to be associated with the development of cancer. Although MCF-7 cell with AtRA is to be the major stimulus for the cell growth and apoptosis, the mechanism of insulin-like growth factor-I (IGF-I)/insulin-like growth factor binding protein-3 (IGFBP-3) system remains to be elucidated. Thus, this study was conducted to the effect of AtRA on the gene expression and level of IGF-I and IGFBP-3. In addition, we investigated the involvement of PKC-${\delta}$ on the IGF-I and IGFBP-3 secretion in MCF-7 cell. AtRA(${\geq}10^{-7}M$) decreased the IGF-1 secretion and mRNA expressions, but increased IGFBP-3 secretion and mRNA expressions in MCF-7 cells. Especially, the treatment of AtRA at 72 hours caused a significant reduction in the IGF-I secretion and mRNA expressions but increment in IGFBP-3 secretion and mRNA expressions (p < 0.05). $10^{-7}M$ AtRA activated PKC-${\delta}$ that is one among PKC-$\iota$, ${\alpha}$, ${\lambda}$ and ${\delta}$ in MCF-7 cell. Rotllerin, a PKC-${\delta}$ inhibitor, blocked AtRA-induced inhibition of the IGF-I and mRNA expressions, and increase of lGFBP-3 and mRNA expressions in MCF-7 cell. Together, AtRA inhibited the IGF-I secretion and mRNA expressions, but increased IGFBP-3 secretion and mRNA expressions in MCF-7 cell. Furthermore, AtRA-induced alteration of IGF-I, IGFBP-3 secretion, and the gene expressions were mediated via PKC-${\delta}$ activity.

다낭성 난포 증후군 환자에서 복강경적 Laser Vaporization 후 내분비적 변화 및 클로미펜에 대한 난소 반응성의 변화 (The Endocrine Changes and Alteration of the Ovarian Response to Clomiphen Citrate after Laparoscopic Laser Vaporization in Patients with Polycystic Ovary Syndrome)

  • 이상준;김진영;박기현;최규홍
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제26권3호
    • /
    • pp.483-490
    • /
    • 1999
  • Objectives: Polycystic ovary syndrome (PCOS) has the feature of excessive LH, hyperandrogenism and disturbance of folliculogenesis. Also, insulin, IGF-I and IGFBP-l are involved in the pathogenesis of PCOS. Various surgical and medical therapies have been used and the action mechanisms are related to the endocrine effect. Laparoscopic ovarian electrocautery or laser vaporization is effective in the restoration of ovulation and normal menstrual cycle with minimal invasive procedure especially in the patients resistant to medical therapy. Clomiphen citrate (CC) is used for the ovulation induction in pcas and the resistance is known to be related to insulin, IGF-I, IGFBP-l levels. This study was performed to evaluate the effect of the laparoscopic laser vaporization on the levels of LH, FSH, testosterone, IGF-I and IGFBP-l and on the ovarian response to clomiphen citrate in patients with CC-resistant PCOS. Materials and Methods: The fasting basal serum LH, FSH, testosterone, IGF-I and IGFBP-l level were measured in 10 PCOS patients with CC-resistance and 7 normal controls with regular menstrual cycle. In PCOS, after laparoscopic $CO_2$ laser vaporization, endocrine levels were measured in 1 week interval for 4 weeks and then compared with preoperative levels. Results: In PCOS group, mean serum LH/FSH ratio, testosterone, IGF-I levels were higher and IGFBP-l level was lower than control. LH/FSH ratio decreased from $2.51{\pm}0.67$ to $1.7{\pm}0.6$ (p<0.05) in 2 weeks, to $0.56{\pm}0.2$ (p<0.01) in 3 weeks and to $1.41{\pm}0.3$ (p<0.01) in 4 weeks after operation. Testosterone level decreased from $1.51{\pm}0.82ng/ml$ to $0.65{\pm}0.34ng/ml$ (p<0.05) in 2 weeks, to $0.56{\pm}0.67ng/ml $(p<0.01) in 3 weeks after operation. IGF-I level also decreased from $436{\pm}47.5{\mu}g/l$ to $187{\pm}38{\mu}g/l$ (p<0.0l) in 1 week, to $167{\pm}42{\mu}g/l$ (p<0.01) in 2 weeks, $179{\pm}55{\mu}g/l$ (p<0.01) in 3 weeks and to $120{\pm}43{\mu}g/l$ (p<0.01) in 4 weeks after operation. IGFBP-l level showed no significant change. In 8 of 10 PCOS patients, ovulation was induced with low dose clomiphen citrate. Conclusion: Laparoscopic $CO_2$ laser vaporization restores normal menstrual cycle and ovulation through endocrine effect of decreasing LH/FSH ratio, testosterone and IGF-I level and increases the response to CC. Therefore it is useful for restoration of normal menstruation and induction of ovulation in CC resistant PCOS patients.

  • PDF

미성숙 돼지 정소에서 pregnancy-associated plasma protein-A의 발현의 세포학적 분석 (Cytological analysis of pregnancy-associated plasma protein-A expression in porcine neonatal testis)

  • 김지윤;오건봉;변승준;옥선아;이휘철;황성수;박상현;하우태;우제석;송혁
    • 한국수정란이식학회지
    • /
    • 제33권3호
    • /
    • pp.177-183
    • /
    • 2018
  • 생체 조직 내에서 표지인자의 발견은 해당 세포의 특성과 기능을 이해하는 데 매우 중요하다. 이전의 연구에서 본 연구진은 돼지정원줄기세포에서 특이적으로 IGFBP 3가 발현되어 표지인자로의 가능성을 보고한 바 있다. 본 연구에서는 IGFBP 3이외의 다른 family member가 정원줄기세포에서 특이적으로 발현하는 지와, 이의 발현을 조절하는 PAPP-A의 조직학적인 측면에서의 발현 양상을 5일령 돼지 정소에서 확인하였다. 그 결과 IGFBP 1, 2, 3, 4, 6의 발현은 정소 전체에서 발현되는 수준보다 돼지 정원줄기세포에서 더 높은 수준에서 발현하고 있음을 확인하였다. PAPP-A는 sertoli cell에서 특이적으로 발현하며, 정원줄기세포에서는 발현하지 않는 것을 PGP9.5와의 동시-조직염색으로 확인하였다. 이러한 결과는 Sertoli cell에서 발현하는 PAPP-A 단백질은 미성숙 돼지 정소에서 IGFBP family를 통해 정소 세포의 발달과 분화를 조절할 것으로 판단된다.

Streptozotocin에 의해 유도된 당뇨쥐의 IGF-I, IGFBPs 및 IGF-I carrier protein의 변화 (Changes of insulin like growth factor-I, IGF-I carrier protein in streptozotocin-induced diabetic rat)

  • 허영란;김송군;김진상;강창원
    • 대한수의학회지
    • /
    • 제40권3호
    • /
    • pp.489-496
    • /
    • 2000
  • 본 연구에서는 Streptozotocin-induced 당뇨가 혈청과 간장 및 신장조직의 IGF-I, IGFBPs 및 IGF-I carrier protein 특성에 미치는 영향을 조사하였다. 혈액과 조직중의 IGF-I 농도는 방사면역측정법으로 측정하였고, IGFBPs 양상은 Western Ligand Blotting(WLB)으로 관찰하였으며, IGF-I carrier protein의 특성은 column chromatography로 측정하였다. 혈청과 IGF-I 농도는 당뇨군이 대조군에 비하여 유의하게 감소하였다 (p<0.01). 당뇨군은 대조군에 비하여 간장 IGF-I 농도는 유의하게 감소한 반면, 신장의 IGF-I 농도는 유의하게 증가하였다(p<0.01). 당뇨군은 대조군에 비하여 혈청과 간장의 IGFBP-3는 감소한 반면, IGFBP-2는 증가하였고, IGFBP-4는 변화가 없었다. 또한 당뇨군은 대조군에 비하여 150kDa carrier protein은 감소하였으며, 50kDa carrier protein은 증가하였다. 이상의 결과를 종합해볼 때 Streptozotocin-induced 당뇨는 혈청 뿐만 아니라 조직의 IGF-I/IGFBP system 변동에 영향을 미침을 알 수 있었다.

  • PDF

비만 청소년에서 Insulin, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3에 대한 연구 (Serum Insulin, Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 Levels in Obese Adolescents)

  • 권정현;김현진;홍영미
    • Clinical and Experimental Pediatrics
    • /
    • 제48권11호
    • /
    • pp.1172-1178
    • /
    • 2005
  • 목 적 : 소아 비만은 전세계적으로 증가하고 있는 추세이며, 신체적으로나 정신적으로 장애를 일으킨다. 특히 고혈압, 관상동맥질환, 당뇨병 등의 성인병이 문제가 되고 있다. 이에 비만 청소년에서 혈중 인슐린, 인슐린저항지수, 유리 지방산, IGF-I, IGFBP-3를 측정하였고, 심혈관 질환으로 진행할 수 있는 위험인자로 유용한지 알아보기 위해 본 연구를 실시하였다. 방 법 : 64명의 중등도 이상의 비만 청소년를 대상군으로 하였고, 같은 연령의 정상 청소년 20명을 대조군으로 하였다. 신장, 체중을 이용하여 비만도와 체질량지수를 산출하였고, 안정된 상태에서 수축기, 이완기 혈압을 측정하였다. 10시간 이상 금식 후 총 콜레스테롤, 중성지방, HDL 콜레스테롤, LDL 콜레스테롤, AST, ALT, 혈당, 인슐린, 유리지방산, IGF-I, IGFBP-3를 측정하였다. 결 과 : 인슐린은 비만군에서 $15.6{\pm}7.0{\mu}IU/mL$로 정상군보다 유의하게 높았고(P<0.01), 인슐린저항지수도 비만군에서 $64.6{\pm}31.6$으로 정상군보다 유의하게 높았다(P<0.01). IGF-I은 비만군에서 $498.1{\pm}122.2ng/mL$로 정상군보다 유의하게 높았고(P<0.05), IGFBP-3도 비만군에서 $3,777{\pm}4,721ng/mL$로 정상군보다 유의하게 높았다(P<0.05). 인슐린은 체질량지수(r=0.394), 비만도(r=0.304)와 양의 상관관계를 나타냈다. IGFBP-3는 비만도(r=0.419), 이완기 혈압(r=0.264), 체질량지수(r=0.247)와 양의 상관관계를 보였다. 인슐린저항지수는 체질량지수(r=0.595), 혈중 중성지방(r=0.515), 비만도(0.469)와 양의 상관관계를 나타냈다. 결 론 : 비만 청소년에서 혈중 인슐린, 인슐린저항지수, IGF-I, IGFBP-3가 증가하였다. 청소년 비만에서 이들 검사는 심혈관질환으로의 진행을 예측하는데 유용하리라 생각한다.